-
J. Cardiothorac. Vasc. Anesth. · Dec 2003
Randomized Controlled Trial Clinical TrialPyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass.
- Albert H Olivencia-Yurvati, James L Blair, Mirza Baig, and Robert T Mallet.
- Department of Surgery, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699, USA. ao-yurvati@hsc.unt.edu
- J. Cardiothorac. Vasc. Anesth. 2003 Dec 1; 17 (6): 715-20.
ObjectivesTo determine whether pyruvate-fortified cardioplegia solution provides cardioprotection superior to lactate-based cardioplegia solutions in patients undergoing elective coronary revascularization, with specific attention to post-surgical recovery of left ventricular performance as well as biochemical markers of ischemic injury.DesignProspective, randomized, semi-blinded human trial.SettingCommunity-based academic medical center.ParticipantsThirty adult patients undergoing elective coronary artery bypass graft surgery.InterventionsPatients were randomized to two 4:1 blood cardioplegia solutions, one pyruvate enhanced and the other lactate based. Hemodynamic and laboratory variables were measured in all patients at pre-cross-clamp, post-cross-clamp, and 4, 6, 8, and 12 hours after bypass.Measurements And Main ResultsRelative to lactate-based cardioplegia, pyruvate-fortified cardioplegia sharply increased left ventricular stroke work at 4 to 12 hours after bypass (p < 0.001), lowered coronary sinus troponin I and creatine phosphokinase-MB activities 67% (p < 0.001) and 53% (p < 0.01), respectively, and increased coronary sinus hemoglobin O(2) saturation 18% (p < 0.001). Ten patients treated with lactate cardioplegia required beta-adrenergic inotropic support postbypass, but only 4 pyruvate-treated patients required beta-adrenergic support (p = 0.067). Pyruvate cardioplegia shortened postsurgery hospitalization from 6.3 +/- 0.3 to 5.2 +/- 0.1 days (p < 0.002).ConclusionsPyruvate-fortified cardioplegia mitigated myocardial injury during coronary artery bypass surgery and facilitated postsurgical recovery of cardiac performance. Thus, pyruvate-enhanced cardioplegia may provide cardioprotection superior to lactate-based solutions during surgical cardiac arrest.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.